# Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy

> **NCT02238444** · PHASE4 · UNKNOWN · sponsor: **Yangzhou University** · enrollment: 60 (estimated)

## Conditions studied

- Cirrhosis
- Hypertension
- Venous Thrombosis
- Status; Splenectomy

## Interventions

- **DRUG:** Warfarin
- **DRUG:** Dipyridamole
- **DRUG:** Aspirin
- **DRUG:** Low Molecular Weight Heparin

## Key facts

- **NCT ID:** NCT02238444
- **Lead sponsor:** Yangzhou University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09-01
- **Primary completion:** 2019-09-30
- **Final completion:** 2019-09-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02238444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02238444, "Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02238444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*